Category Archives: Health

Latest From Health

New Study: 340B Entities Not Using the Program as Intended

lab_tech02

A new analysis released by Avalere Health and funded by the Alliance for Integrity and Reform of 340B (AIR 340B) found hospitals participating in the 340B drug pricing program were more likely to acquire independent physician practices than non-340B hospitals. This study looks beyond past research on hospital acquisitions, which largely focused on the higher costs associated with the acquisition of physician practices, to the likelihood of acquisitions among 340B and non-340B entities. This research provides Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Convergence of BioPharma and Digital Medicine

Dr. Eric Topol

Our newfound capability of digitizing the medical essence of human beings with biosensors, imaging, sequencing and other biologic omics (A “Google Medical Map” of Each Individual) will be the foundation for a new era of medicine — one that is datafied and democratized. Most of the leading biopharma companies have already begun to embrace digital medicine, through partnerships with online health communities, particularly Patients Like Me or via biosensors in a variety of conditions including Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Time: How to Breathe New Life Into America’s Health-Care System

21st Century Cures Act

Last week, Rep. Fred Upton (R-MI) published an op-ed – How to Breathe New Life Into America’s Health-Care System – in Time Magazine on the potential of the 21st Century Cures Act to ‘help modernize the health-care innovation infrastructure, incorporate a patient perspective into the drug and device approval process, support advances in personalized medicine, streamline clinical trials, and provide more resources to support cutting-edge research and help young scientists.’ Rep. Upton points out that there are Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Out of Africa: Biomedical Innovation and Expertise

stethoscope

Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden of disease on the world’s populations. Developing countries, such as those in sub-Saharan Africa, are disproportionately encumbered by disease – many of which are endemic only to those geographies.  Yet these same regions are a wellspring of innovative and creative ideas that are being used to advance biomedical science and healthcare product development. Research centers within these regions are yet Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About ‘Big Pharma’

lab_tech02

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big myths about big pharma in this Forbes opinion piece. He points to these five biggest industry myths as ‘routinely poisoning debates, obscuring genuine problems, and distorting policy recommendations on health care.’ In short (excerpts): Myth #1 Pharmaceutical companies exaggerate the costs of developing new medicines to justify high prices. In fact: The research and development (R&D) expenditures of this industry Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,